TABLE 3.

Eradication rate accessed by a negative stool test according to characteristics of 139 children treated for Helicobacter pylori (H. pylori) infection

Characteristics	N	Success %	OR	P	aOR	P
Age (years)				0.09		0.09
<11	97	60.8	1		1
≥11	42	45.2	0.53 (0.26–1.11)		0.41 (0.15–1.14)
Gender				0.02		0.02
Boys	70	65.7	2.22 (1.12–4.39)		3.04 (1.20–7.73)
Girls	69	46.4	1		1
Living area				0.59		0.71
Provinces	58	53.5	1		1
Ho Chi Minh City	81	58.0	1.20 (0.61–2.37)		1.18 (0.49–2.83)
+ Rural	49	53.1	1
+ Urban	32	65.6	1.69 (0.67–4.24)	0.26
History of pretreatment*				0.69		0.22
Yes	32	59.4	1.18 (0.53–2.64)		2.00 (0.67–5.92)
No	103	55.3	1		1
Malnutrition				0.01		0.03
Yes	22	31.8	0.30 (0.11–0.80)		0.27 (0.08–0.87)
No	117	60.7	1		1
Endoscopic findings				0.52		0.74
Ulcers	35	51.4	0.78 (0.36–1.67)		1.19 (0.44–3.23)
Gastritis	104	57.7	1		1
cagA status†				0.01		0.02
Positive	101	49.5	0.36 (0.16–0.83)		0.25 (0.08–0.78)
Negative	37	73.0	1		1
vacA genotypes†				0.73		0.69
s1/m1	44	54.6	0.60 (0.10–3.62)		0.70 (0.09–5.51)
s1/m2	56	58.9	0.72 (0.12–4.25)		0.35 (0.04–2.94)
s2/m2	1	100	1		1
Mixed infections	31	48.4	0.47 (0.07–2.94)		0.46 (0.06–3.62)
Incomplete vacA	6	66.7
Antibiotic susceptibility to regimens‡				0.61
Susceptible to 2 ATB	38	55.3	1
Resistance to 1 ATB	16	68.8	1.78 (0.52–6.13)
Resistance to 2 ATB	4	50.0	0.81 (0.10–6.36)
Side effects§				0.66		0.99
Yes	19	63.2	1.26 (0.45–3.46)		0.99 (0.32–3.10)
No	97	57.7	1		1
Compliance with treatment∥				0.89		0.65
Yes	96	58.3	1.07 (0.40–2.86)		1.32 (0.40–4.29)
No	20	60.0	1		1

aOR = adjusted odds ratio; ATB = antibiotics; OR, odds ratio.

*Four missing data.

†One missing data.

‡Antimicrobial susceptibility testing results were available in 58 patients.

§Information on side effects was available on 115 patients.

∥Information on compliance with treatment was available on 116 patients.